澳洋健康
(002172)
| 流通市值：45.22亿 | | | 总市值：45.25亿 |
| 流通股本：7.65亿 | | | 总股本：7.66亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,248,567,827.99 | 822,546,484.46 | 406,693,952.2 | 1,806,837,366.11 |
| 营业收入 | 1,248,567,827.99 | 822,546,484.46 | 406,693,952.2 | 1,806,837,366.11 |
| 二、营业总成本 | 1,206,987,661.4 | 795,003,665.61 | 396,403,863.58 | 1,744,055,248.13 |
| 营业成本 | 1,096,614,776.49 | 723,482,031.5 | 356,618,362.28 | 1,559,442,805.39 |
| 税金及附加 | 8,376,218.73 | 5,355,997.69 | 2,897,281.7 | 11,549,774.08 |
| 销售费用 | 23,020,287.76 | 15,523,914.47 | 7,567,245.15 | 35,555,790.4 |
| 管理费用 | 61,419,421.88 | 37,014,540.75 | 21,315,165.52 | 102,160,704.82 |
| 财务费用 | 17,556,956.54 | 13,627,181.2 | 8,005,808.93 | 35,346,173.44 |
| 其中:利息费用 | 18,339,502.43 | 13,281,109.21 | 8,291,809.64 | 29,545,120.2 |
| 其中:利息收入 | 2,825,514.25 | 1,160,810.08 | 787,429.32 | 3,887,457.61 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | - | -300,000 |
| 加:投资收益 | -577,315.67 | -427,315.67 | -206,755.44 | 2,154,386.5 |
| 资产处置收益 | 20,441.06 | 20,441.06 | - | 6,876.33 |
| 资产减值损失(新) | - | - | - | -2,446,403.96 |
| 信用减值损失(新) | -8,673.63 | 1,267,841.54 | -1,986,428.64 | -13,928,058.48 |
| 其他收益 | 8,069,763.68 | 4,116,649.74 | 259,083.79 | 16,090,187.98 |
| 四、营业利润 | 49,084,382.03 | 32,520,435.52 | 8,355,988.33 | 64,359,106.35 |
| 加:营业外收入 | 7,150,116.4 | 3,586,047.83 | 582,706.93 | 2,950,687.7 |
| 减:营业外支出 | 2,581,621.65 | 1,419,784.3 | 1,175,558.42 | 7,610,566.14 |
| 五、利润总额 | 53,652,876.78 | 34,686,699.05 | 7,763,136.84 | 59,699,227.91 |
| 减:所得税费用 | 16,254,783.63 | 10,541,034.2 | 2,567,635.25 | 17,814,481.53 |
| 六、净利润 | 37,398,093.15 | 24,145,664.85 | 5,195,501.59 | 41,884,746.38 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 37,398,093.15 | 24,145,664.85 | 5,195,501.59 | 41,884,746.38 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 37,487,330.84 | 24,164,685.97 | 5,236,055.46 | 41,291,338.02 |
| 少数股东损益 | -89,237.69 | -19,021.12 | -40,553.87 | 593,408.36 |
| 扣除非经常损益后的净利润 | 27,624,797.24 | 19,246,312.77 | 5,486,451.2 | 24,536,832.61 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.05 | 0.03 | 0.01 | 0.05 |
| (二)稀释每股收益 | 0.04 | 0.03 | 0.01 | 0.05 |
| 八、其他综合收益 | - | - | - | 117,033.58 |
| 归属于母公司股东的其他综合收益 | - | - | - | 117,033.58 |
| 九、综合收益总额 | 37,398,093.15 | 24,145,664.85 | 5,195,501.59 | 42,001,779.96 |
| 归属于母公司股东的综合收益总额 | 37,487,330.84 | 24,164,685.97 | 5,236,055.46 | 41,408,371.6 |
| 归属于少数股东的综合收益总额 | -89,237.69 | -19,021.12 | -40,553.87 | 593,408.36 |
| 公告日期 | 2026-10-23 | 2026-08-18 | 2026-04-30 | 2026-03-31 |
| 审计意见(境内) | | | | 标准无保留意见 |